Skip to content
Back to IMMX

Immix Biopharma, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
2
Purchases
2
Sales
0
Purchase value
$10.04K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Ilya M RachmanDirector · CEO and Chairman
4
Filed Dec 10, 2025Period of report Dec 10, 20250001493152-25-027109
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 10, 2025
Common Stock746$6.67$4.98K1,141,683Direct
Open on SEC EDGAR
Gabriel S MorrisDirector · CFO
4
Filed Dec 10, 2025Period of report Dec 8, 20250001493152-25-027107
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 10, 2025
Common Stock770$6.58$5.07K291,429Direct
Filing footnotes · 3
  1. F1Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
  2. F2Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
  3. F3The warrants were held by Alwaysraise LLC.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.